69 Enrolled - Lantheus Medical Imaging
Lantheus PET Imaging: A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD).
Our sites enrolled a very large number of patients for Lantheus. Katy Cardiology enrolled 55 patients and became the global highest enrolling site! There were over 100 sites involved, so this was an amazing accomplishment.
Northwest Houston Heart Center also enrolled 14 patients, again a strong achievement for this study.
Overall, our two sites combined accounted for 7.9% of the total enrolled patients in this study.